(2024). Wilkins CR, Zwicker JI, Derkach A, Burge M. Impact of romiplostim on overall survival in chemotherapy induced thrombocytopenia. Blood. 2023;142(suppl 1): 801-802. Blood, 144(24), 2560. https://doi.org/10.1182/blood.2024024692
Chicago Style (17th ed.) Citation"Wilkins CR, Zwicker JI, Derkach A, Burge M. Impact of Romiplostim on Overall Survival in Chemotherapy Induced Thrombocytopenia. Blood. 2023;142(suppl 1): 801-802." Blood 144, no. 24 (2024): 2560. https://doi.org/10.1182/blood.2024024692.
MLA (9th ed.) Citation"Wilkins CR, Zwicker JI, Derkach A, Burge M. Impact of Romiplostim on Overall Survival in Chemotherapy Induced Thrombocytopenia. Blood. 2023;142(suppl 1): 801-802." Blood, vol. 144, no. 24, 2024, p. 2560, https://doi.org/10.1182/blood.2024024692.
